PDF herunterladen
Thromb Haemost 1998; 80(02): 349-350
DOI: 10.1055/s-0037-1615206
Letters to the Editor
Schattauer GmbH

Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants (LA)

Armando Tripodi
1   Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Institute of Internal Medicine, University and IRCCS Maggiore Hospital, Milano, Italy
,
Pier Mannuccio Mannucci
1   Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Institute of Internal Medicine, University and IRCCS Maggiore Hospital, Milano, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 23. Januar 1998

Accepted after revision 02. April 1998

Publikationsdatum:
08. Dezember 2017 (online)

    Lizenzen und Reprints

 

 

  • References

  • 1 Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants.. Ann Int Med 1998; 127: 177-85.
    PubMedGoogle Scholar
  • 2 Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome.. Brit J Haematol 1998; 98: 887-92.
    PubMedGoogle Scholar
  • 3 Della Valle P, Crippa L, Safa O, Tomassini L, Pattarini E, Vigano’-D’Angelo S, Sabbadini MG, D’Angelo A. Potential failure on the International Normalized Ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants.. Ann Med Interne 1996; 147 (Suppl. 01) 10-4.
    PubMedGoogle Scholar
  • 4 WHO Expert Committee on Biological Standardization.. Guidelines for thromboplastin and plasma used to control oral anticoagulant therapy.. To be published. Technical Report Series 1998.
    PubMedGoogle Scholar